Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.466.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.78NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.82NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.79.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.99NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.343NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.409NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.310NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.362.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.162NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Y.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.154NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.137NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.446NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used